I agree Cro, this is just sell bio-tech earnings regardless emotion. Market cap of 60 million, the facility is worth more than that and Atryn HD is worth that too IMO. The programs are advancing, the partners we have, LEO, LFB, Merrimack, Pharmathene, these are all vested in GTC success and selling here is just not warranted. I know it sounds dumb, but I believe we will go over $1 this quarter without a R/S